Si-Bone
SIBN
19.10
-0.45
-2.30%
Si-Bone
US · SIBN
#3357 by market cap
Listed 2018
19.10
-0.45
-2.30%
Live - 5344 symbols - heartbeat 238s ago
· 2026-10-08 08:44
Pre-market
19.10
0.00%
After-hours
19.10
0.00%
- Market cap
- 856.03M
- P/E (TTM)i
- -57.88
- P/Bi
- 4.69
- EPSi
- -0.44
- Div yieldi
- 0.00%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on SIBN?
Anonymous reader poll. Unscientific, not investment advice.
About Si-Bone
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.
- Founded
- 2008
- CEO
- Ms. Laura A. Francis
- Employees
- 559
- Headquarters
- Santa Clara, California, United States of America
- Fiscal year end
- 12-31
- Website
- si-bone.com
Company profile
- Exchange
- US
- Symbol
- SIBN
- Market-cap rank
- #3357
- Listing date
- 2018-10-18
- Market cap
- 856.03M
- Float cap
- 763.76M
- Shares out
- 44.82M
- Float shares
- 39.99M
Sectors & themes
Quote time 2026-10-08 08:44:03 · For reference only, not investment advice and not tailored to your situation.